Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.
Aminoglycosides
Brucella abortus
Brucella melitensis
Gentamicin
Streptomycin
Journal
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
ISSN: 1678-4405
Titre abrégé: Braz J Microbiol
Pays: Brazil
ID NLM: 101095924
Informations de publication
Date de publication:
16 Jan 2024
16 Jan 2024
Historique:
received:
12
06
2023
accepted:
28
11
2023
medline:
17
1
2024
pubmed:
17
1
2024
entrez:
16
1
2024
Statut:
aheadofprint
Résumé
Aminoglycosides are vital antibiotics for treating Brucella infections, because they interfere with bacterial protein production and are often combined with other antibiotics. They are cost-effective, have fewer side effects, and can penetrate biofilms. The prevalence of brucellosis has increased in recent years, increasing the need for effective treatments. In addition, the emergence of multidrug-resistant Brucella strains has highlighted the need for an updated and comprehensive understanding of aminoglycoside resistance. This systematic review aimed to provide a comprehensive overview of the global prevalence of aminoglycoside resistance in B. melitensis and B. abortus. A systematic search of online databases was conducted and eligible studies met certain criteria and were published in English. Quality assessment was performed using the JBI Checklist. A random-effects model was fitted to the data, and meta-regression, subgroup, and outlier/influential analyses were performed. The analysis was performed using R and the metafor package. The results of this systematic review and meta-analysis suggested that the average prevalence rates of streptomycin, gentamicin, and amikacin resistance were 0.027 (95% confidence interval [CI], 0.015-0.049), 0.023 (95% CI, 0.017-0.032), and 0.008 (95% CI, 0.002-0.039), respectively. The prevalence of streptomycin resistance was higher in the unidentified Brucella group than in the B. abortus and B. melitensis groups (0.234, 0.046, and 0.017, respectively; p < 0.02). The prevalence of gentamicin resistance increased over time (r = 0.064; 95% CI, 0.018 to 0.111; p = 0.007). The prevalence of resistance did not correlate with the quality score for any antibiotic. Funnel plots showed a potential asymmetry for streptomycin and gentamicin. These results suggest a low prevalence of antibiotic resistance in the studied populations. The prevalence of aminoglycoside resistance in B. melitensis and B. abortus was low. However, gentamicin resistance has increased in recent years. This review provides a comprehensive and updated understanding of aminoglycoside resistance in B. melitensis and B. abortus.
Identifiants
pubmed: 38228936
doi: 10.1007/s42770-023-01233-6
pii: 10.1007/s42770-023-01233-6
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
Références
Hashim R, Ahmad N, Mohamed Zahidi J, Tay BY, Mohd Noor A, Zainal S et al (2014) Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis. Int J Microbiol 2014:596245. https://doi.org/10.1155/2014/596245
doi: 10.1155/2014/596245
pubmed: 25120569
pmcid: 4121247
Hassoun-Kheir N, Stabholz Y, Kreft JU, de la Cruz R, Romalde JL, Nesme J et al (2020) Comparison of antibiotic-resistant bacteria and antibiotic resistance genes abundance in hospital and community wastewater: a systematic review. Sci Total Environ 743:140804. https://doi.org/10.1016/j.scitotenv.2020.140804
doi: 10.1016/j.scitotenv.2020.140804
pubmed: 32758846
Elbehiry A, Aldubaib M, Al Rugaie O, Marzouk E, Moussa I, El-Husseiny M et al (2022) Brucella species-induced brucellosis: antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles. PLoS One 17(7):e0269963. https://doi.org/10.1371/journal.pone.0269963
doi: 10.1371/journal.pone.0269963
pubmed: 35834538
pmcid: 9282596
Founou RC, Founou LL, Essack SY (2017) Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One 12(12):e0189621. https://doi.org/10.1371/journal.pone.0189621
doi: 10.1371/journal.pone.0189621
pubmed: 29267306
pmcid: 5739407
Gultekin E, Uyanik MH, Albayrak A, Kilic S (2021) Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey. Eur J Med Res 26(1):57. https://doi.org/10.1186/s40001-021-00527-5
doi: 10.1186/s40001-021-00527-5
pubmed: 34134763
pmcid: 8207786
Elbehiry A, Aldubaib M, Al Rugaie O, Marzouk E, Abaalkhail M, Moussa I et al (2022) Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical Brucella species: an evolution of brucellosis infection control. PLoS One 17(1):e0262551. https://doi.org/10.1371/journal.pone.0262551
doi: 10.1371/journal.pone.0262551
pubmed: 35025975
pmcid: 8757992
Vidal L, Gafter-Gvili A, Borok S, Fraser A, Leibovici L, Paul M (2007) Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 60(2):247–257. https://doi.org/10.1093/jac/dkm193
doi: 10.1093/jac/dkm193
pubmed: 17562680
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F (2017) Chapter 7: systematic reviews of etiology and risk . In: Aromataris E, Munn Z (eds) Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute. Available
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188. https://doi.org/10.1016/0197-2456(86)90046-2
doi: 10.1016/0197-2456(86)90046-2
pubmed: 3802833
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129
doi: 10.2307/3001666
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186
doi: 10.1002/sim.1186
pubmed: 12111919
Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ 342:d549. https://doi.org/10.1136/bmj.d549
doi: 10.1136/bmj.d549
pubmed: 21310794
Viechtbauer W, Cheung MW (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1(2):112–125. https://doi.org/10.1002/jrsm.11
doi: 10.1002/jrsm.11
pubmed: 26061377
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
doi: 10.2307/2533446
pubmed: 7786990
Sterne JAC, Egger M (2005) Regression methods to detect publication and other bias in meta-analysis. In: Rothstein HR, Sutton AJ, Borenstein M (eds) Publication bias in meta-analysis: prevention, assessment and adjustment p 99–110, Wiley.
Team RC R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-projectorg/. 2013
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48
doi: 10.18637/jss.v036.i03
Qadri SM, Lee GC, Ellis ME (1991) In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials. Chemotherapy 37(3):166–174. https://doi.org/10.1159/000238850
doi: 10.1159/000238850
pubmed: 1889304
Qadri SM, Ueno Y, Ayub A (1993) Anti-Brucella activity of Ro 23–9424, a dual-action antibacterial. Chemotherapy 39(6):386–389. https://doi.org/10.1159/000238981
doi: 10.1159/000238981
pubmed: 8222864
Qadri SM, Ueno Y (1993) Susceptibility of Brucella melitensis to the new fluoroquinolone PD 131628: comparison with other drugs. Chemotherapy 39(2):128–131. https://doi.org/10.1159/000239114
doi: 10.1159/000239114
pubmed: 8384544
Qadri SM, Akhter J, Ueno Y, Saldin H (1993) In vitro activity of eight fluoroquinolones against clinical isolates of Brucella melitensis. Ann Saudi Med 13(1):37–40. https://doi.org/10.5144/0256-4947.1993.37
doi: 10.5144/0256-4947.1993.37
pubmed: 17587989
Qadri SMH, Cunha BA, Al-Ahdal MN, Ueno Y, Qadri SG (1995) Antibrucella activity of quinolone sparfloxacin. J Travel Med 2(4):229–231. https://doi.org/10.1111/j.1708-8305.1995.tb00665.x
doi: 10.1111/j.1708-8305.1995.tb00665.x
pubmed: 9815397
Qadri SM, Halim MA, Ueno Y, Abumustafa FM, Postle AG (1995) Antibacterial activity of azithromycin against Brucella melitensis. Chemotherapy 41(4):253–256. https://doi.org/10.1159/000239353
doi: 10.1159/000239353
pubmed: 7555205
Turkmani A, Ioannidis A, Christidou A, Psaroulaki A, Loukaides F, Tselentis Y (2006) In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Ann Clin Microbiol Antimicrob 5:24. https://doi.org/10.1186/1476-0711-5-24
doi: 10.1186/1476-0711-5-24
pubmed: 17014707
pmcid: 1617115
Ayaşlioǧlu E, Kiliç S, Aydin K, Kiliç D, Kaygusuz S, Aǧalar C (2008) Antimicrobial susceptibility of Brucella melitensis isolates from blood samples. Turk J Med Sci 38(3):257–262
Altun B, Hasçelik G, Gür D (2009) In vitro activity of tigecycline against Brucella spp. Med J Trakya Univ 26(3):261–263
Ozhak-Baysan B, Ongut G, Ogunc D, Gunseren F, Sepin-Ozen N, Ozturk F et al (2010) Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp. Pol J Microbiol 59(1):55–60
doi: 10.33073/pjm-2010-008
pubmed: 20568531
Lonsway DR, Jevitt LA, Uhl JR, Cockerill FR 3rd, Anderson ME, Sullivan MM et al (2010) Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp. J Clin Microbiol 48(3):952–956. https://doi.org/10.1128/JCM.01860-09
doi: 10.1128/JCM.01860-09
pubmed: 20032255
Jiang H, Mao LL, Zhao HY, Li LY, Piao DR, Yao WQ, Cui BY (2010) MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. Trans R Soc Trop Med Hyg 104(12):796–800. https://doi.org/10.1016/j.trstmh.2010.08.002
doi: 10.1016/j.trstmh.2010.08.002
pubmed: 20832094
Castillo R, Guillen A, Espinosa B, Meza R, Espinoza N, Nunez G et al (2010) Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Antimicrob Agents Chemother 110:A-023
Maves RC, Castillo R, Guillen A, Espinosa B, Meza R, Espinoza N et al (2011) Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Antimicrob Agents Chemother 55(3):1279–1281. https://doi.org/10.1128/AAC.00979-10
doi: 10.1128/AAC.00979-10
pubmed: 21199926
pmcid: 3067062
Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, Dueger E (2012) In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob 11:24. https://doi.org/10.1186/1476-0711-11-24
doi: 10.1186/1476-0711-11-24
pubmed: 22929054
pmcid: 3464789
Qadri SMH, Ueno Y (2012) Susceptibility of Brucella melitensis to the New Fluoroquinolone CI-960. Drug Investig 3(5):365–367. https://doi.org/10.1007/bf03259754
doi: 10.1007/bf03259754
Rahmani MR, Rashidi A, Hakhamaneshi MS, Shapouri R, Zandi F, Hazhir MS et al (2012) Evaluation of the antibacterial activity of Zataria multiflora Boiss, Rhus coriaria L. (sumac), Mentha piperita L., and Ocimum basilicum L. extracts on Brucella strains isolated from brucellosis patients. Turk J Med Sci 42(5):816–22. https://doi.org/10.3906/sag-1106-39
doi: 10.3906/sag-1106-39
Yayli G, AkÇAm FZ, Kaya O (2012) Investigation of the in vitro activities of various antibiotics against Brucella melitensis strains. Turk J Med Sci 42(1):145–148. https://doi.org/10.3906/sag-1009-1129
doi: 10.3906/sag-1009-1129
Safi M, Al-Mariri A (2012) Efficacy evaluation of some antibiotics against syrian brucella spp isolates, in vitro. Braz J Microbiol [Internet]. 43(4):1269–73. Available from: https://doi.org/10.1590/S1517-83822012000400005
Kasymbekov J, Imanseitov J, Ballif M, Schurch N, Paniga S, Pilo P et al (2013) Molecular epidemiology and antibiotic susceptibility of livestock Brucella melitensis isolates from Naryn Oblast, Kyrgyzstan. PLoS Negl Trop Dis 7(2):e2047. https://doi.org/10.1371/journal.pntd.0002047
doi: 10.1371/journal.pntd.0002047
pubmed: 23469294
pmcid: 3584998
Ilhan Z, Solmaz H, Ekin IH (2013) In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey. J Vet Med Sci 75(8):1035–1040. https://doi.org/10.1292/jvms.12-0163
doi: 10.1292/jvms.12-0163
pubmed: 23545462
Parlak M, Guducuoglu H, Bayram Y, Cikman A, Aypak C, Kilic S, Berktas M (2013) Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods. Int J Med Sci 10(10):1406–1411. https://doi.org/10.7150/ijms.6565
doi: 10.7150/ijms.6565
pubmed: 23983603
pmcid: 3753419
Al-Mariri A, Safi M (2013) Effect of medium pH on antibiotic activity against Syrian Brucella spp. isolates. Iran J Med Sci 38(3):248–54
pubmed: 24174696
pmcid: 3808949
Neto AM, Corção G, Dasso MG, Keid LB, Costa Md (2014) Antimicrobial susceptibility profile of Brucella spp. isolated in Brazil. Rev Patol Trop 43(2):163–72. https://doi.org/10.5216/rpt.v43i2.31110
doi: 10.5216/rpt.v43i2.31110
Barbosa Pauletti R, ReinatoStynen AP, da Silva Pinto, Mol J, Seles Dorneles EM, Alves TM, de Sousa Moura Souto M et al (2015) Reduced susceptibility to rifampicin and resistance to multiple antimicrobial agents among Brucella abortus isolates from cattle in Brazil. PLoS One 10(7):e0132532. https://doi.org/10.1371/journal.pone.0132532
doi: 10.1371/journal.pone.0132532
pubmed: 26181775
pmcid: 4504493
Etiz P, Kibar F, Ekenoglu Y, Yaman A (2015) Characterization of antibiotic susceptibility of brucella spp isolates with E-Test method. Arch Clin Microbiol 6:1
Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S et al (2015) In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014–2015. BMC Microbiol 15:121. https://doi.org/10.1186/s12866-015-0458-9
doi: 10.1186/s12866-015-0458-9
pubmed: 26073177
pmcid: 4466872
Pauletti RB, Stynen APR, Mol JPDS, Dorneles EMS, Alves, TM, Souto MSM de et al (2015) Distribution of the susceptibility profile to seven antimicrobials for the 147 B. abortus strains isolated from cattle in Brazil, 1977–2009, according to the year of isolation. PLOS ONE. Dataset. https://doi.org/10.1371/journal.pone.0132532.t003
Razzaghi R, Rastegar R, Momen-Heravi M, Erami M, Nazeri M (2016) Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran. Indian J Med Microbiol 34(3):342–345. https://doi.org/10.4103/0255-0857.188336
doi: 10.4103/0255-0857.188336
pubmed: 27514957
Irajian GR, MasjedianJazi F, Mirnejad R, Piranfar V, ZahraeiSalehi T, Amir Mozafari N et al (2016) Species-specific PCR for the diagnosis and determination of antibiotic susceptibilities of Brucella strains isolated from Tehran. Iran Iran J Pathol 11(3):238–247
pubmed: 27799972
TorkamanAsadi F, Hashemi SH, Alikhani MY, Moghimbeigi A, Naseri Z (2017) Clinical and diagnostic aspects of brucellosis and antimicrobial susceptibility of Brucella isolates in Hamedan. Iran Jpn J Infect Dis 70(3):235–238. https://doi.org/10.7883/yoken.JJID.2016.133
doi: 10.7883/yoken.JJID.2016.133
Shevtsov A, Syzdykov M, Kuznetsov A, Shustov A, Shevtsova E, Berdimuratova K et al (2017) Antimicrobial susceptibility of Brucella melitensis in Kazakhstan. Antimicrob Resist Infect Control 6:130. https://doi.org/10.1186/s13756-017-0293-x
doi: 10.1186/s13756-017-0293-x
pubmed: 29299304
pmcid: 5745643
Mohammadi Azad Z, Moravej H, Fasihi-Ramandi M, Masjedian F, Nazari R, Mirnejad R, Moosazadeh MM (2017) In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis. J Med Microbiol 66(7):919–926. https://doi.org/10.1099/jmm.0.000524
doi: 10.1099/jmm.0.000524
pubmed: 28699872
Liu ZG, Di DD, Wang M, Liu RH, Zhao HY, Piao DR et al (2018) In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China. BMC Infect Dis 18(1):43. https://doi.org/10.1186/s12879-018-2947-6
doi: 10.1186/s12879-018-2947-6
pubmed: 29338693
pmcid: 5771123
Johansen TB, Scheffer L, Jensen VK, Bohlin J, Feruglio SL (2018) Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective. Sci Rep 8(1):8538. https://doi.org/10.1038/s41598-018-26906-3
doi: 10.1038/s41598-018-26906-3
pubmed: 29867163
pmcid: 5986768
Khan AU, Shell WS, Melzer F, Sayour AE, Ramadan ES, Elschner MC et al (2019) Identification, genotyping and antimicrobial susceptibility testing of Brucella spp. isolated from livestock in Egypt. Microorganisms 7:12. https://doi.org/10.3390/microorganisms7120603
doi: 10.3390/microorganisms7120603
Alamian S, Dadar M, Etemadi A, Afshar D, Alamian MM (2019) Antimicrobial susceptibility of Brucella spp. isolated from Iranian patients during 2016 to 2018. Iran J Microbiol 11(5):363–7
pubmed: 32148665
pmcid: 7049315
Nobegani AS, Motamedifar M (2019) Antibiotic sensitivity profile of the bacterial isolates from the blood samples of the patients in different wards of a major referral hospital, SHIRAZ, IRAN 2015–2016. Pharmacophore 10(2):30–6
Khan S, Akhtar MU, Khan S, Javed F, Khan AA (2020) Nanoniosome-encapsulated levoflaxicin as an antibacterial agent against Brucella. J Basic Microbiol 60(3):281–290. https://doi.org/10.1002/jobm.201900454
doi: 10.1002/jobm.201900454
pubmed: 31856360
Yuan HT, Wang CL, Liu LN, Wang D, Li D, Li ZJ, Liu ZG (2020) Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China. Infect Dis Poverty 9(1):79. https://doi.org/10.1186/s40249-020-00697-0
doi: 10.1186/s40249-020-00697-0
pubmed: 32600403
pmcid: 7325291
Elbehiry A, Aldubaib M, Al Rugaie O, Marzouk E, Abaalkhail M, Moussa I, El-Husseiny MH, Abalkhail A, Rawway M (2022) Proteomics-based screening and antibiotic resistance assessment of clinical and sub-clinical Brucella species: an evolution of brucellosis infection control. PLoS One. 17(1):e0262551. https://doi.org/10.1371/journal.pone.0262551
Arapovic J, Kompes G, Dedic K, Teskeredzic S, Ostojic M, Travar M et al (2022) Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: the first multicentre study in Bosnia and Herzegovina. J Glob Antimicrob Resist 29:99–104. https://doi.org/10.1016/j.jgar.2022.02.005
doi: 10.1016/j.jgar.2022.02.005
pubmed: 35182775
Tscherne A, Mantel E, Boskani T, Budniak S, Elschner M, Fasanella A et al (2022) Adaptation of Brucella melitensis antimicrobial susceptibility testing to the ISO 20776 standard and validation of the method. Microorganisms 10:7. https://doi.org/10.3390/microorganisms10071470
doi: 10.3390/microorganisms10071470
Safi M, Al-Mariri A (2012) Efficacy evaluation of some antibiotics against syrian Brucella spp isolates, in vitro. Braz J Microbiol 43:1269–1273
doi: 10.1590/S1517-83822012000400005
pubmed: 24031952
pmcid: 3769035
Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M (2008) Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ 336(7646):701–704. https://doi.org/10.1136/bmj.39497.500903.25
doi: 10.1136/bmj.39497.500903.25
pubmed: 18321957
pmcid: 2276295
RezaeiShahrabi A, Moradkasani S, Goodarzi F, Beig M, Sholeh M (2023) Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: a systematic review and meta-analysis. Microb Pathog 183:106321. https://doi.org/10.1016/j.micpath.2023.106321
doi: 10.1016/j.micpath.2023.106321
Beig M, Moradkasani S, Goodarzi F, Sholeh M (2023) Prevalence of Brucella melitensis and Brucella abortus fluoroquinolones resistant isolates: a systematic review and meta-analysis. Vector Borne Zoonotic Dis. https://doi.org/10.1089/vbz.2023.0063
doi: 10.1089/vbz.2023.0063
pubmed: 37862228